Developing an aptamer, graphene based electrochemical biosensor for early detection of Alzheimer disease.

At least 50 million people are living with Alzheimer disease (AD) worldwide and the number is estimated to grow to 150 million by 2050 making it a global epidemy. AD in the sixth cause of death in north America and its estimated cost of caring is $277 billion yearly, yet no cure is available for AD. This is partly because current diagnostic techniques are expensive- ranging from $1500 to $6000- or invasive- require lumbar punctures-, which makes early screening and disease monitoring difficult. In this work we would develop a cost-effective and non-invasive biosensor, capable of detecting multiple biomarkers from blood samples of preclinical and clinical AD patients.

Faculty Supervisor:

Mahla Poudineh

Student:

Fatemeh Keyvani

Partner:

Health Message Technologies

Discipline:

Other

Sector:

Other

University:

University of Waterloo